(SUPN) Supernus Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Supernus Pharmaceuticals | (SUPN) share price targets
Complete technical analysis of Supernus Pharmaceuticals (SUPN) by charts plus indicators, forecast predictions and share price targets for Supernus Pharmaceuticals (SUPN)
Supernus Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-11-20 View latest technical analysis
10 day averaged volume of Supernus Pharmaceuticals is 439700
Date | Daily Closing Price | Open | High | Low | Volume |
20 Wed Nov 2024 | 36.12 | 35.66 | 36.50 | 35.32 | 0.464 times |
19 Tue Nov 2024 | 35.53 | 34.88 | 35.64 | 34.88 | 0.481 times |
18 Mon Nov 2024 | 35.25 | 35.61 | 36.20 | 34.86 | 0.509 times |
15 Fri Nov 2024 | 35.57 | 36.39 | 36.39 | 35.23 | 0.917 times |
14 Thu Nov 2024 | 36.18 | 37.78 | 38.32 | 35.87 | 0.844 times |
13 Wed Nov 2024 | 37.77 | 37.94 | 38.32 | 37.18 | 0.918 times |
12 Tue Nov 2024 | 37.83 | 36.84 | 37.99 | 36.84 | 0.968 times |
11 Mon Nov 2024 | 36.61 | 36.93 | 37.27 | 36.02 | 0.606 times |
08 Fri Nov 2024 | 36.60 | 36.50 | 36.78 | 35.87 | 1.316 times |
07 Thu Nov 2024 | 36.40 | 37.75 | 37.75 | 36.23 | 1.793 times |
My analysis of stock is bullish for shortterm, and stock might move up till 36.8 or till 38.4. Use a stoploss of 35.51 and if this stock hits its stoploss, then it can fall down till 34.2
Share price targets for Supernus Pharmaceuticals (SUPN)
Target Type | Value |
Downside Target | 25.55 |
Downside Target | 27.05 |
Downside Target | 29.50 |
Downside Target | 30.83 |
Downside Target | 33.27 |
Downside Target | 34.54 |
Downside Target | 35.41 |
Downside Target | 35.56 |
Upside Target | 36.50 |
Upside Target | 38.32 |
Upside Target | 39.37 |
Intraday share price targets for Supernus Pharmaceuticals (SUPN)
Target Type | Value |
Downside Intraday Target | 35.15 |
Downside Intraday Target | 34.19 |
Upside Intraday Target | 36.79 |
Upside Intraday Target | 37.47 |
Downside Intraday Target | 35.83 |
Weekly technical analysis of Supernus Pharmaceuticals (SUPN)
Date | Weekly Closing Price | Open | High | Low | Volume |
20 Wed Nov 2024 | 36.12 | 35.61 | 36.50 | 34.86 | 0.342 times |
15 Fri Nov 2024 | 35.57 | 36.93 | 38.32 | 35.23 | 0.536 times |
08 Fri Nov 2024 | 36.60 | 33.96 | 39.37 | 33.43 | 1.706 times |
01 Fri Nov 2024 | 33.97 | 34.32 | 35.56 | 33.73 | 1.955 times |
25 Fri Oct 2024 | 33.93 | 34.53 | 34.54 | 33.27 | 0.807 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Supernus Pharmaceuticals (SUPN)
Date | Monthly Closing Price | Open | High | Low | Volume |
20 Wed Nov 2024 | 36.12 | 34.22 | 39.37 | 33.43 | 1.077 times |
31 Thu Oct 2024 | 34.07 | 31.10 | 35.56 | 30.83 | 0.765 times |
30 Mon Sep 2024 | 31.18 | 34.90 | 35.15 | 29.50 | 0.771 times |
30 Fri Aug 2024 | 35.16 | 29.78 | 35.41 | 27.05 | 1.117 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Supernus Pharmaceuticals (SUPN)
Price action analysis of Supernus Pharmaceuticals ( (SUPN) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Supernus Pharmaceuticals ( (SUPN) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Supernus Pharmaceuticals ( (SUPN) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Supernus Pharmaceuticals ( (SUPN) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Supernus Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Supernus Pharmaceuticals in short term but the sell signal is initial and weak.
Supernus Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Supernus Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Supernus Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 36.51 and Supernus Pharmaceuticals (SUPN) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Supernus Pharmaceuticals (SUPN) stock. Volume based technical analysis of Supernus Pharmaceuticals (SUPN) stock is negative.
Supernus Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Supernus Pharmaceuticals ( (SUPN) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Supernus Pharmaceuticals ( (SUPN) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Supernus Pharmaceuticals ( (SUPN) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Supernus Pharmaceuticals ( (SUPN) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Supernus Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Supernus Pharmaceuticals in short term but the sell signal is initial and weak.
Supernus Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Supernus Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Supernus Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 36.51 and Supernus Pharmaceuticals (SUPN) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Supernus Pharmaceuticals (SUPN) stock. Volume based technical analysis of Supernus Pharmaceuticals (SUPN) stock is negative.
Supernus Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.